| Â | BM (g) | TAT (g) |
|---|
| Â |
d 0
|
d 41
|
d 0
|
d 41
|
CH-Intact
| 226 ± 6 | 298 ± 9###
| 18 ± 1 | 33 ± 4##
|
CH-OVX
| 226 ± 6 | 357 ± 10*+
| 19 ± 1 | 51 ± 2*+
|
CH-OVX+E2
| 226 ± 7 | 281 ± 7 | 20 ± 1 | 34 ± 3 |
EN-Intact
| 226 ± 7 | 363 ± 7* | 19 ± 1 | 84 ± 4* |
EN-OVX
| 229 ± 7 | 399 ± 19+ϕ
| 18 ± 2 | 95 ± 10 |
EN-OVX+E2
| 233 ± 8 | 356 ± 14 | 20 ± 1 | 83 ± 7 |
- Initial (d 0) and final (d 41) body mass (BM) and total adipose tissue (TAT) mass, determined with microCT, of chow- and Ensure-fed intact rats (CH-Intact and EN-Intact), ovariectomized rats (CH-OVX and EN-OVX), and estradiol-treated ovariectomized rats (CH-OVX+E2 and EN-OVX+E2), means ± SEM. Initial and final levels in CH-Intact rats were compared with t-tests to characterize normal maturational changes. Group differences on d 41 were analyzed by planned comparisons, with experiment-wide significance P < 0.05, as described in the text.
-
#Different from d 0, P < 0.05, ##P < 0.01, ###P < 0.001;
- *Different from CH-Intact;
-
+OVX different from OVX+E2, same diet group;
-
Ï•EN-OVX different from EN-Intact.
